In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors

Acta Tropica

Volumn 112, Issue 1, 2009, Pages 12-15

  Wisedpanichkij, Raewadee ^a   Chaijaroenkul, Wanna ^a   Sangsuwan, Piyanan ^a   Tantisawat, Jintana ^a   Boonprasert, Kanyarat ^a   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Antimalarial interaction; In vitro; Isobologram; Ketoconazole; Mefloquine; Plasmodium falciparum; Quinidine

Indexed keywords

CHLOROQUINE; CLARITHROMYCIN; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DISULFIRAM; FLUCONAZOLE; KETOCONAZOLE; MEFLOQUINE; QUINIDINE; SULFAPHENAZOLE;

CLONE; CYTOCHROME; DISEASE CONTROL; DISEASE TREATMENT; DRUG RESISTANCE; ENZYME ACTIVITY; INHIBITOR; MALARIA; SYNERGISM;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; SCHIZONT;

ANIMALS; ANTIMALARIALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; KETOCONAZOLE; MEFLOQUINE; PLASMODIUM FALCIPARUM; QUINIDINE;

PLASMODIUM FALCIPARUM;

EID: 68249103379     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.05.018     Document Type: Article

References (28)

1. Awasthi A., Dutta G.P., Bhakuni V., and Tripathi R. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis. Exp. Parasitol. 107 3-4 (2004) 115-119
2. Barrett J. Cytochrome P450 in parasitic protozoa and helminthes. Comp. Biochem. Physiol: C 121 (1998) 181-183
3. Bell A. Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiol. Lett. 253 (2005) 171-184
4. Boudreau E.F., Webster H.K., Pavanand K., and Thosingha L. Type II mefloquine resistance in Thailand. Lancet 2 8311 (1982) 1335
5. Bwijo B., Alin M.H., Abbas N., Wernsdorfer W., and Björkman A. Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics. Trop. Med. Int. Health 2 5 (1997) 461-467
6. Chong C.R., and Salivan Jr. D.J. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem. Pharmacol. 66 (2003) 2201-2212
7. Congpuong K., Na-Bangchang K., Mungthin M., Bualombai P., and Wernsdorfer W.H. Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand. Trop. Med. Int. Health 10 8 (2005) 717-722
8. Ekins S., Stresser D.M., and Williams J.A. In vitro and pharmacophore insights into CYP3A enzymes. Trends Pharmacol. Sci. 24 (2003) 161-166
9. Fivelman Q.L., Adagu I.S., and Warhurst D.C. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48 11 (2004) 4097-4102
10. Fontaine F., de Sousa G., Burcham P.C., Duchêne P., and Rahmani R. Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes. Life Sci. 66 22 (2000) 2193-2212
11. Gupta S., Thapar M.M., Wernsdorfer W.H., and Björkman A. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 46 5 (2002) 1510-1515
12. Kang J., Chen X.L., Wang L., and Rampe D. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG. J. Pharmacol. Exp. Ther. 299 1 (2001) 290-296
13. Karbwang J., Na-Bangchang K., Thanavibul A., Back D.J., and Bunnag D. Pharmacokinetics of mefloquine in the presence of primaquine. Eur. J. Clin. Pharmacol. 42 (1992) 559-560
14. Lambros C., and Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65 3 (1979) 418-420
15. Macreadie I., Ginsburg H., Sirawaraporn W., and Tilley L. Antimalarial drug development and new targets. Parasitol. Today 16 10 (2000) 438-444
16. Na-Bangchang K., Karbwang J., and Back D.J. Mefloquine metabolism by human liver microsomes: effect of other antimalarial drugs. Biochem. Pharmacol. 43 9 (1992) 1957-1961
17. Na-Bangchang K., Bray P.G., and Ward S.A. Study on biochemical basis of mefloquine resistant Plasmodium falciparum. Expt. Parasitol. 117 (2007) 141-148
18. Nosten F., Kuile F., Chongsuphajaisiddhi T., Luxemburger C., Webster H.K., et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337 8750 (1991) 1140-1143
19. Palmer K.J., Holliday S.M., and Brogden R.N. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45 3 (1993) 430-475
20. Rieckmann K.H., Campbell G.H., Sax L.J., and Mrema J.E. Drug sensitivity of Plasmodium falciparum. An in-vitro microtechnique. Lancet 1 8054 (1978) 22-23
21. Ridtitid W., Wongnawa M., Mahatthanatrakul W., Raungsri N., and Sunbhanich M. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. J. Clin. Pharm. Ther. 30 3 (2005) 285-290
22. Ruangweerayut R., Looareesuwan S., Hutchinson D., Chauemung A., Banmairuroi V., and Na-Bangchang K. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria. Malaria J. 7 (2008) 225-235
23. Rungsihirunrat K., Chaijareonkulb W., Seugorna A., Na-Bangchang K., and Thaithong S. Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Acta Trop. 109 (2009) 37-40
24. Schlagenhauf P. Mefloquine for malaria chemoprophylaxis 1992-1998: a review. J. Travel. Med. 6 (1999) 122-133
25. Toovey S. Mefloquine neurotoxicity: a literature review. Travel. Med. Infect. Dis. 7 1 (2009) 2-6
26. Trager W., and Jensen J. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
27. Tripathi R., Awasthi A., and Dutta G.P. Mefloquine resistance reversal action of-a cytochrome P450 inhibitor, against mefloquine-resistant malaria. Parasitology 130 (2005) 475-479
28. Tsunoda S.M., Velez R.L., Von Moltke L.L., et al. Differentiation of intestinal and hepatic cytochrome P4503A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Clin. Pharmacol. Ther. 66 (1999) 461-471